In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Ex Input:
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stop Government Shutdowns Act''.

SEC. 2. AUTOMATIC CONTINUATION OF FEDERAL FUNDING.

    (a) In General.--If, as a result of a failure to enact a regular or 
continuing appropriation Act or joint resolution, there is a lapse in 
appropriations for any projects or activities of the Federal Government 
that were conducted in the previous fiscal year, and for which 
appropriations, funds, or other authority were made available in such 
fiscal year, there is appropriated, out of any money in the Treasury 
not otherwise appropriated, and out of applicable corporate or other 
revenues, receipts, and funds, such amounts as may be necessary for 
continuing such projects or activities (including the costs of direct 
loans and loan guarantees), at the current rate for operations and 
under the authority and conditions provided in the applicable 
appropriation Act or Acts that provided funds for the project or 
activity for the previous fiscal year.
    (b) Continuation Period.--Appropriations and funds made available 
and authority granted for a project or activity pursuant to this Act 
shall be available until whichever of the following first occurs:
            (1) the enactment into law of an appropriation for such 
        project or activity;
            (2) the enactment into law of the applicable appropriation 
        Act for such fiscal year without any provision for such project 
        or activity; or
            (3) the last day of the fiscal year for which such 
        appropriations and funds are made available or such authority 
        is granted for such project or activity pursuant to subsection 
        (a).

SEC. 3. AVAILABILITY OF FUNDS.

    (a) Extent and Manner.--Appropriations made by section 2(a) shall 
be available to the extent and in the manner that would be provided by 
the applicable appropriation Act.
    (b) Coverage.--Appropriations made and authority granted pursuant 
to this Act shall cover all obligations or expenditures incurred for 
any project or activity during the period for which funds or authority 
for such project or activity are available under this Act.

SEC. 4. USE OF FUNDS.

    (a) No New Starts.--No appropriation or funds made available or 
authority granted pursuant to section 2(a) shall be used to initiate or 
resume any project or activity for which appropriations, funds, or 
other authority were not available during the previous fiscal year.
    (b) Apportionment Timing.--Appropriations made and funds made 
available by or authority granted pursuant to this Act may be used 
without regard to the time limitations for submission and approval of 
apportionments set forth in section 1513 of title 31, United States 
Code, but nothing in this Act may be construed to waive any other 
provision of law governing the apportionment of funds.
    (c) High Rates for Operation.--Notwithstanding any other provision 
of this Act, except section 2(b), for those programs that would 
otherwise have high rates for operation or complete distribution of 
appropriations in the period for which appropriations for such programs 
are made available under this Act because of distributions of funding 
to States, foreign countries, grantees, or others, such high initial 
rates for operation or complete distribution shall not be made, and no 
grants shall be awarded for such programs funded by this Act that would 
impinge on final funding prerogatives.
    (d) Limited Funding Actions.--This Act shall be implemented so that 
only the most limited funding action of that permitted in the Act shall 
be taken in order to provide for continuation of projects and 
activities.
    (e) Prevention of Furloughs.--Amounts made available under section 
2(a) for civilian personnel compensation and benefits in each 
department and agency may be apportioned up to the rate for operations 
necessary to avoid furloughs within such department or agency, 
consistent with the applicable appropriation Act for the previous 
fiscal year, except that such authority provided under this section 
shall not be used until after the department or agency has taken all 
necessary actions to reduce or defer non-personnel-related 
administrative expenses.
    (f) Pay for Members of the Armed Forces.--During a period in which 
appropriations are made available under this Act for the pay of members 
of the Armed Forces, the rate of pay for such members shall not be 
decreased by reason of this Act.
    (g) Application of Certain Authorization Requirements.--Funds 
appropriated by this Act may be obligated and expended notwithstanding 
section 10 of Public Law 91-672 (22 U.S.C. 2412), section 15 of the 
State Department Basic Authorities Act of 1956 (22 U.S.C. 2680), 
section 313 of the Foreign Relations Authorization Act, Fiscal Years 
1994 and 1995 (22 U.S.C. 6212), and section 504(a)(1) of the National 
Security Act of 1947 (50 U.S.C. 414(a)(1)).

SEC. 5. ADJUSTMENT OF ACCOUNTS.

    Expenditures made pursuant to this Act shall be charged to the 
applicable appropriation, fund, or authorization whenever a bill in 
which such applicable appropriation, fund, or authorization is 
contained is enacted into law.

SEC. 6. ENTITLEMENTS AND OTHER MANDATORY PROGRAMS.

    (a) For entitlements and other mandatory payments whose budget 
authority was provided in previous appropriation Acts, and for 
activities under the Food and Nutrition Act of 2008, activities shall 
be continued at the rate to maintain program levels under current law, 
under the authority and conditions provided in the applicable 
appropriation Act for the previous fiscal year, to be continued through 
the date on which appropriations for such programs under this Act 
expire (as specified in section 2(b)).
    (b) Notwithstanding section 2(b)(3), obligations for mandatory 
payments due on or about the first day of any month that begins after 
the first month in which appropriations for such programs are made 
under this Act but not later than 30 days after the date on which 
appropriations for such programs under this Act expire (as specified in 
section 2(b)(3)) may continue to be made, and funds shall be available 
for such payments.

Ex Output:
Stop Government Shutdowns Act - Appropriates amounts for continuing federal projects and activities at the current rate for operations and under the authority and conditions provided in the applicable appropriation Act or Acts that provided funds for them for the previous fiscal year if, as a result of a failure to enact a regular or continuing appropriation Act or joint resolution, there is a lapse in appropriations for such projects or activities.

 Makes appropriations, funds, and authority granted in this Act available until the earliest of: (1) the enactment into law of an appropriation for the project or activity concerned, (2) the enactment into law of the applicable appropriation Act for such fiscal year without any provision for such project or activity, or (3) the last day of the fiscal year for which such appropriations and funds are made available or such authority is granted for such project or activity.

Prohibits appropriations or funds made available or authority granted pursuant to this Act from being used to initiate or resume any project or activity for which appropriations, funds, or other authority were not available during the previous fiscal year.

Authorizes the use of appropriations or funds made available or authority granted without regard to specified time limitations for submission and approval of apportionments requirements; but declares that nothing in this Act may be construed to waive any other provision of law governing the apportionment of funds.

Prescribes requirements for: (1) denial of high rates for operation or complete distribution of appropriations in the lapsed-appropriations period, (2) the most limited funding action for continuation of projects and activities, and (3) apportionment of funds for civilian personnel compensation and benefits as necessary to avoid furloughs. Prohibits any decrease in the pay for members of the Armed Forces during a lapsed-appropriations period.

Requires expenditures made pursuant to this Act to be charged to the applicable appropriation, fund, or authorization whenever an appropriations bill is subsequently enacted into law.

Continues at a specified maintenance rate, through the date on which appropriations for such programs under this Act expires, certain activities with respect to entitlements and other mandatory payments whose budget authority was provided in previous appropriations Acts, as well as for activities under the Food and Nutrition Act of 2008.


Ex Input:
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Drug Competition Act of 2002''.

SEC. 2. FINDINGS.

    Congress finds that--
            (1) prescription drug prices are increasing at an alarming 
        rate and are a major worry of many senior citizens and American 
        families;
            (2) there is a potential for companies with patent rights 
        regarding brand name drugs and companies which could 
        manufacture generic versions of such drugs to enter into 
        financial deals that could tend to restrain trade and greatly 
        reduce competition and increase prescription drug expenditures 
        for American citizens; and
            (3) enhancing competition among these companies can 
        significantly reduce prescription drug expenditures for 
        Americans.

SEC. 3. PURPOSES.

    The purposes of this Act are--
            (1) to provide timely notice to the Department of Justice 
        and the Federal Trade Commission regarding agreements between 
        companies with patent rights regarding brand name drugs and 
        companies which could manufacture generic versions of such 
        drugs; and
            (2) by providing timely notice, to enhance the 
        effectiveness and efficiency of the enforcement of the 
        antitrust and competition laws of the United States.

SEC. 4. DEFINITIONS.

    In this Act:
            (1) ANDA.--The term ``ANDA'' means an Abbreviated New Drug 
        Application, as defined under section 201(aa) of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 321(aa)).
            (2) Assistant attorney general.--The term ``Assistant 
        Attorney General'' means the Assistant Attorney General in 
        charge of the Antitrust Division of the Department of Justice.
            (3) Brand name drug.--The term ``brand name drug'' means a 
        drug approved under section 505(c) of the Federal Food, Drug, 
        and Cosmetic Act (21 U.S.C. 355(c)).
            (4) Brand name drug company.--The term ``brand name drug 
        company'' means the party that received Food and Drug 
        Administration approval to market a brand name drug pursuant to 
        an NDA, where that drug is the subject of an ANDA, or a party 
        owning or controlling enforcement of any patent listed in the 
        Approved Drug Products With Therapeutic Equivalence Evaluations 
        of the Food and Drug Administration for that drug, under 
        section 505(b) of the Federal Food, Drug, and Cosmetic Act (21 
        U.S.C. 355(b)).
            (5) Commission.--The term ``Commission'' means the Federal 
        Trade Commission.
            (6) Generic drug.--The term ``generic drug'' means a 
        product that the Food and Drug Administration has approved 
        under section 505(j) of the Federal Food, Drug, and Cosmetic 
        Act (21 U.S.C. 355(j)).
            (7) Generic drug applicant.--The term ``generic drug 
        applicant'' means a person who has filed or received approval 
        for an ANDA under section 505(j) of the Federal Food, Drug, and 
        Cosmetic Act (21 U.S.C. 355(j)).
            (8) NDA.--The term ``NDA'' means a New Drug Application, as 
        defined under section 505(b) et seq. of the Federal Food, Drug, 
        and Cosmetic Act (21 U.S.C. 355(b) et seq.)

SEC. 5. NOTIFICATION OF AGREEMENTS.

    (a) In General.--
            (1) Requirement.--A generic drug applicant that has 
        submitted an ANDA containing a certification under section 
        505(j)(2)(vii)(IV) of the Federal Food, Drug, and Cosmetic Act 
        (21 U.S.C. 355(j)(2)(vii)(IV)) and a brand name drug company 
        that enter into an agreement described in paragraph (2), prior 
        to the generic drug that is the subject of the application 
        entering the market, shall each file the agreement as required 
        by subsection (b).
            (2) Definition.--An agreement described in this paragraph 
        is an agreement regarding--
                    (A) the manufacture, marketing or sale of the brand 
                name drug that is the subject of the generic drug 
                applicant's ANDA;
                    (B) the manufacture, marketing or sale of the 
                generic drug that is the subject of the generic drug 
                applicant's ANDA; or
                    (C) the 180-day period referred to in section 
                505(j)(5)(B)(iv) of the Federal Food, Drug, and 
                Cosmetic Act (21 U.S.C. 355(j)(5)(B)(iv)) as it applies 
                to such ANDA or to any other ANDA based on the same 
                brand name drug.
    (b) Filing.--
            (1) Agreement.--The generic drug applicant and the brand 
        name drug company entering into an agreement described in 
        subsection (a)(2) shall file with the Assistant Attorney 
        General and the Commission the text of any such agreement, 
        except that the generic drug applicant and the brand-name drug 
        company shall not be required to file an agreement that solely 
        concerns--
                    (A) purchase orders for raw material supplies;
                    (B) equipment and facility contracts;
                    (C) employment or consulting contracts; or
                    (D) packaging and labeling contracts.
            (2) Other agreements.--The generic drug applicant and the 
        brand name drug company entering into an agreement described in 
        subsection (a)(2) shall file with the Assistant Attorney 
        General and the Commission the text of any other agreements not 
        described in subsection (a)(2) between the generic drug 
        applicant and the brand name drug company which are contingent 
        upon, provide a contingent condition for, or are otherwise 
        related to an agreement which must be filed under this Act.
            (3) Description.--In the event that any agreement required 
        to be filed by paragraph (1) or (2) has not been reduced to 
        text, both the generic drug applicant and the brand name drug 
        company shall file written descriptions of the non-textual 
        agreement or agreements that must be filed sufficient to reveal 
        all of the terms of the agreement or agreements.

SEC. 6. FILING DEADLINES.

    Any filing required under section 5 shall be filed with the 
Assistant Attorney General and the Commission not later than 10 
business days after the date the agreements are executed.

SEC. 7. DISCLOSURE EXEMPTION.

    Any information or documentary material filed with the Assistant 
Attorney General or the Commission pursuant to this Act shall be exempt 
from disclosure under section 552 of title 5, and no such information 
or documentary material may be made public, except as may be relevant 
to any administrative or judicial action or proceeding. Nothing in this 
section is intended to prevent disclosure to either body of Congress or 
to any duly authorized committee or subcommittee of the Congress.

SEC. 8. ENFORCEMENT.

    (a) Civil Penalty.--Any brand name drug company or generic drug 
applicant which fails to comply with any provision of this Act shall be 
liable for a civil penalty of not more than $11,000, for each day 
during which such entity is in violation of this Act. Such penalty may 
be recovered in a civil action brought by the United States, or brought 
by the Commission in accordance with the procedures established in 
section 16(a)(1) of the Federal Trade Commission Act (15 U.S.C. 56(a)).
    (b) Compliance and Equitable Relief.--If any brand name drug 
company or generic drug applicant fails to comply with any provision of 
this Act, the United States district court may order compliance, and 
may grant such other equitable relief as the court in its discretion 
determines necessary or appropriate, upon application of the Assistant 
Attorney General or the Commission.

SEC. 9. RULEMAKING.

    The Commission, with the concurrence of the Assistant Attorney 
General and by rule in accordance with section 553 of title 5 United 
States Code, consistent with the purposes of this Act--
            (1) may define the terms used in this Act;
            (2) may exempt classes of persons or agreements from the 
        requirements of this Act; and
            (3) may prescribe such other rules as may be necessary and 
        appropriate to carry out the purposes of this Act.

SEC. 10. SAVINGS CLAUSE.

    Any action taken by the Assistant Attorney General or the 
Commission, or any failure of the Assistant Attorney General or the 
Commission to take action, under this Act shall not bar any proceeding 
or any action with respect to any agreement between a brand name drug 
company and a generic drug applicant at any time under any other 
provision of law, nor shall any filing under this Act constitute or 
create a presumption of any violation of any antitrust or competition 
laws.

SEC. 11. EFFECTIVE DATE.

    This Act shall--
            (1) take effect 30 days after the date of enactment of this 
        Act; and
            (2) shall apply to agreements described in section 5 that 
        are entered into 30 days after the date of enactment of this 
        Act.

            Passed the Senate November 18, 2002.

            Attest:

                                                  JERI THOMSON,

                                                             Secretary.

Ex Output:
Drug Competition Act of 2002 - (Sec. 5) Requires a generic drug applicant that has submitted an Abbreviated New Drug Application (ANDA) and a brand name drug company that enter into an agreement, prior to the generic drug entering the market, regarding the manufacture, marketing, or sale of the brand name or the generic drug, or regarding the 180-day semi-exclusivity period referred to in the Federal Food, Drug, and Cosmetic Act as it applies to such ANDA or any other ANDA based on the same brand name drug, to each file such agreement and any related agreements with the Assistant Attorney General and the Federal Trade Commission (FTC). Makes an exception for agreements that solely concern purchase orders for raw material supplies, equipment and facility contracts, or employment or consulting contracts. Requires such agreements to be filed not later than ten business days after the date they are executed.(Sec. 7) Exempts any such information or documentary material filed from disclosure under the Freedom of Information Act. Prohibits such information or material from being made public, except as relevant to any administrative or judicial action or proceeding.(Sec. 8) Subjects an applicant or company to a civil penalty of up to $11,000 for each day such entity fails to comply with this Act, recoverable in a civil action brought by the United States or the FTC. Authorizes a U.S. district court to order compliance and grant equitable relief.


Ex Input:
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Action for Dental Health Act of 
2015''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) More than 181 million Americans will not visit a 
        dentist even though nearly half of people over 30 suffer from 
        some form of gum disease and nearly one in four children under 
        the age of five already have cavities.
            (2) Many volunteer dental projects sponsored by national, 
        State, and local dental societies provide free care now to 
        those most in need. Annually, dentists deliver an estimated 
        $2.6 billion in free and discounted care according to the 
        America's Dentists Care Foundation.
            (3) It is estimated that emergency department (ED) charges 
        for dental complaints totaled up to $2.1 billion in 2010. 
        Nearly 80 percent of the dental emergency room visits were 
        nonurgent and could have been seen in a dental office. Shifting 
        those ED visits to a dental office translates into potential 
        cost savings of up to $1.7 billion a year and offers the 
        possibility of establishing a ``dental home'' for these 
        individuals.
            (4) Seniors, especially those in nursing homes and long-
        term care facilities, often have special dental needs and 
        complicated medical histories that require consultation between 
        dentists and fellow medical professionals in providing an 
        interdisciplinary approach to their overall health needs.

SEC. 3. VOLUNTEER DENTAL PROJECTS AND ACTION FOR DENTAL HEALTH PROGRAM.

    Part B of title III of the Public Health Service Act is revised by 
amending section 317M (42 U.S.C. 247b-14) as follows:
            (1) by redesignating subsections (e) and (f) as (g) and 
        (h), respectively;
            (2) by inserting after subsection (d), the following:
    ``(e) Grants To Support Volunteer Dental Projects.--
            ``(1) In general.--The Secretary, acting through the 
        Director of the Centers for Disease Control and Prevention, may 
        award grants to or enter into contracts with eligible entities 
        to obtain portable or mobile dental equipment, and pay for 
        appropriate operational costs, for the provision of free dental 
        services to underserved populations that are delivered in a 
        manner consistent with State licensing laws.
            ``(2) Eligible entity.--In this subsection, the term 
        `eligible entity' includes a State or local dental association, 
        a State oral health program, a dental education, dental hygiene 
        education, or postdoctoral dental education program accredited 
        by the Commission on Dental Accreditation, and a community-
        based organization that partners with an academic institution, 
        that--
                    ``(A) is exempt from tax under section 501(c) of 
                the Internal Revenue Code of 1986; and
                    ``(B) offers a free dental services program for 
                underserved populations.
    ``(f) Action for Dental Health Program.--
            ``(1) In general.--The Secretary, acting through the 
        Director of the Centers for Disease Control and Prevention, may 
        award grants to or enter into contracts with eligible entities 
        to collaborate with State, county, or local public officials 
        and other stakeholders to develop and implement initiatives to 
        accomplish any of the following goals:
                    ``(A) To improve oral health education and dental 
                disease prevention, including community-wide prevention 
                programs, use of dental sealants and fluoride varnish, 
                and increasing oral health literacy.
                    ``(B) To make the health care delivery system 
                providing dental services more accessible and efficient 
                through the development and expansion of outreach 
                programs that will facilitate the establishment of 
                dental homes for children and adults, including the 
                aged, blind, and disabled populations.
                    ``(C) To reduce geographic, language, cultural, and 
                similar barriers in the provision of dental services.
                    ``(D) To help reduce the use of emergency 
                departments by those who seek dental services more 
                appropriately delivered in a dental primary care 
                setting.
                    ``(E) To facilitate the provision of dental care to 
                nursing home residents who are disproportionately 
                affected by lack of care.
            ``(2) Eligible entity.--In this subsection, the term 
        `eligible entity' includes a State or local dental association, 
        a State oral health program, or a dental education, dental 
        hygiene, or postdoctoral dental education program accredited by 
        the Commission on Dental Accreditation, and a community-based 
        organization that partners with an academic institution, that--
                    ``(A) is exempt from tax under section 501(c) of 
                the Internal Revenue Code of 1986; and
                    ``(B) partners with public and private stakeholders 
                to facilitate the provision of dental services for 
                underserved populations.''; and
            (3) in subsection (h), as redesignated by paragraph (1), by 
        striking ``fiscal years 2001 through 2005'' and inserting 
        ``fiscal years 2016 through 2020''.

Ex Output:

Action for Dental Health Act 2015 This bill amends the Public Health Service Act to reauthorize oral health promotion and disease prevention programs through FY2020.  The Centers for Disease Control and Prevention (CDC) may award grants or enter into contracts to obtain portable or mobile dental equipment and pay operational costs for the provision of free dental services to underserved populations. The CDC may also award grants or enter into contracts to collaborate with state, county, or local public officials and other stakeholders to develop and implement initiatives to: (1) improve oral health education and dental disease prevention; (2) make the health care delivery system providing dental services more accessible and efficient through the development and expansion of outreach programs that facilitate the establishment of dental homes; (3) reduce geographic, language, cultural, and similar barriers in the provision of dental services; (4) reduce the use of emergency departments by those who seek dental services more appropriately delivered in a dental primary care setting; or (5) facilitate the provision of dental care to nursing home residents who are disproportionately affected by lack of care.